FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "SCA Pharmaceuticals, LLC(037559301)" | Succinylcholine Chloride | 20 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Succinylcholine Chloride | 20 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Epinephrine | .02 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Epinephrine | .032 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Epinephrine | .016 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .025 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .01 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .01 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .01 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .01 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .05 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .02 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .01 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate; Ropivacaine Hydrochloride | .002 mg/1 mL; 2 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Hydromorphone Hydrochloride | .2 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Hydromorphone Hydrochloride | .2 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Hydromorphone Hydrochloride | .2 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Hydromorphone Hydrochloride | 1 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Ketamine Hydrochloride | 10 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Ketamine Hydrochloride | 10 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Lidocaine Hydrochloride | 20 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Methadone Hydrochloride | 10 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Phenylephrine Hydrochloride | .1 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Phenylephrine Hydrochloride | .08 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Phenylephrine Hydrochloride | .2 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Phenylephrine Hydrochloride | .16 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Phenylephrine Hydrochloride | .08 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Phenylephrine Hydrochloride | .04 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Phenylephrine Hydrochloride | .1 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Phenylephrine Hydrochloride | .04 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Phenylephrine Hydrochloride | .1 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Phenylephrine Hydrochloride | .1 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Phenylephrine Hydrochloride | .4 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Potassium Chloride | 20 meq/250 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Potassium Chloride | 40 meq/500 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Rocuronium Bromide | 10 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Rocuronium Bromide | 10 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Succinylcholine Chloride | 20 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Succinylcholine Chloride | 20 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Sugammadex Sodium | 100 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Sugammadex Sodium | 10 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Sugammadex Sodium | 50 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Sugammadex Sodium | 50 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Sugammadex Sodium | 50 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Trisodium Citrate Dihydrate | 40 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Vancomycin Hydrochloride | 1.75 g/500 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Vancomycin Hydrochloride | 1.5 g/500 mL | 2025-2 | source_no_ndc | 2026-10-06 |